Turnbull Jeffrey, Caskey Joshua, Alsalahi Ammar, Griepp Daniel W, Desai Shivum, Richards Boyd, Kelkar Prashant, Claus Chad F, Griauzde Julius
Departments of1Neurosurgery and.
2Interventional Radiology, Henry Ford Providence Hospital, Southfield, Michigan.
J Neurosurg. 2025 Jul 25:1-6. doi: 10.3171/2025.3.JNS242385.
Chronic subdural hematoma (cSDH) recurrence is a significant cause of morbidity in neurosurgical patients. Middle meningeal artery embolization (MMAe) effectively reduces cSDH recurrence by targeting its associated inflammatory cascade. Delayed recanalization can occur from proximal branches of the middle meningeal artery (MMA) after use of particle embolic agents. Surgeons may utilize coil embolization in addition to particle embolic agents to achieve proximal vessel control. This study compares reaccumulation rates for cSDH patients undergoing particle embolization of the MMA with and without coil embolization.
A retrospective review of prospectively collected data was performed on the records of patients who underwent particle MMAe with or without coils for cSDH at the authors' institution from 2021 to 2023 The primary outcome was cSDH recurrence at CT follow-up at least 1 month after MMAe.
Sixty-two patients underwent 81 embolization procedures with particles alone (n = 32) or particles and coils (n = 49). There was no significant difference in recurrence between particles versus particles and coils (6.3% vs 10.2%, p = 0.698). There was a statistical difference in procedure length (54.8 ± 28.7 vs 85.9 ± 26.5 minutes, p < 0.001) and fluoroscopy time (34.9 ± 20.8 vs 48.8 ± 24.7 minutes, p = 0.01) between patients who underwent particle embolization versus those who underwent embolization with particles and coils. A noninferiority analysis demonstrated no significant difference between groups in treatment failure, hematoma expansion, and follow-up size > 1 cm.
In the setting of cSDH, MMAe using particles only versus particles with coils shows similar rates of hematoma reaccumulation and resolution. Procedural time and fluoroscopy time were significantly reduced within the particle embolization-alone cohort. When comparing hematoma resolution and expansion, follow-up hematoma size > 1 cm, and decrease in hematoma size > 1 cm between groups, embolization using particles alone was not inferior to embolization using particles supplemented with coils.
慢性硬膜下血肿(cSDH)复发是神经外科患者发病的重要原因。脑膜中动脉栓塞术(MMAe)通过针对其相关的炎症级联反应有效降低cSDH复发率。使用颗粒栓塞剂后,脑膜中动脉(MMA)近端分支可能发生延迟再通。除颗粒栓塞剂外,外科医生可采用弹簧圈栓塞术来实现近端血管控制。本研究比较了接受颗粒栓塞MMA的cSDH患者在有无弹簧圈栓塞情况下的血肿再积聚率。
对2021年至2023年在作者所在机构接受有或无弹簧圈的颗粒MMAe治疗cSDH的患者记录进行回顾性分析,这些数据是前瞻性收集的。主要结局是在MMAe后至少1个月的CT随访中cSDH复发情况。
62例患者接受了81次栓塞手术,其中单纯使用颗粒(n = 32)或颗粒加弹簧圈(n = 49)。单纯颗粒栓塞与颗粒加弹簧圈栓塞的复发率无显著差异(6.3%对10.2%,p = 0.698)。单纯颗粒栓塞患者与颗粒加弹簧圈栓塞患者在手术时长(54.8 ± 28.7对85.9 ± 26.5分钟,p < 0.001)和透视时间(34.9 ± 20.8对48.8 ± 24.7分钟,p = 0.01)方面存在统计学差异。非劣效性分析表明,两组在治疗失败、血肿扩大和随访时血肿大小>1 cm方面无显著差异。
在cSDH的治疗中,单纯使用颗粒进行MMAe与使用颗粒加弹簧圈进行MMAe的血肿再积聚率和消散率相似。单纯颗粒栓塞组的手术时间和透视时间显著缩短。在比较两组间的血肿消散和扩大情况、随访时血肿大小>1 cm以及血肿大小减小>1 cm时,单纯使用颗粒栓塞并不劣于使用颗粒加弹簧圈栓塞。